Shanghai Haohai Biological Technology Co. Ltd Cash Flow Quality Index
Shanghai Haohai Biological Technology Co. Ltd cash flow quality index. Shanghai Haohai Biological Technology Co. Ltd (5HB) has a Cash Flow Quality Index of 1.38x as of June 2023. Operating cash flow of €141.99 Million exceeds net income of €102.62 Million, indicating high earnings quality where cash backs reported profits. See Shanghai Haohai Biological Technology Co financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Shanghai Haohai Biological Technology Co. Ltd (2016–2025)
Cash flow quality index of Shanghai Haohai Biological Technology Co. Ltd from 2016 to 2025. Historical Cash Flow Quality Index for Shanghai Haohai Biological Technology Co. Ltd across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore Shanghai Haohai Biological Technology Co debt service capacity to assess how comfortably operating cash covers total debt obligations.
Shanghai Haohai Biological Technology Co. Ltd Cash Flow Quality Index by Year (2016–2025)
Shanghai Haohai Biological Technology Co. Ltd cash flow quality index by year from 2016 to 2025. Year-by-year earnings quality comparison for Shanghai Haohai Biological Technology Co. Ltd. For the full cash flow conversion analysis, see 5HB cash flow conversion.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.96x | €490.97 Million | €251.01 Million | ▲ +26.8% |
| 2024 | 1.54x | €648.57 Million | €420.45 Million | ▲ +1.2% |
| 2023 | 1.52x | €634.45 Million | €416.12 Million | ▲ +19.0% |
| 2022 | 1.28x | €231.30 Million | €180.47 Million | ▲ +32.0% |
| 2021 | 0.97x | €342.29 Million | €352.45 Million | ▼ -14.7% |
| 2020 | 1.14x | €262.07 Million | €230.07 Million | ▲ +21.0% |
| 2019 | 0.94x | €348.91 Million | €370.78 Million | ▼ -0.3% |
| 2018 | 0.94x | €391.28 Million | €414.54 Million | ▲ +2.5% |
| 2017 | 0.92x | €343.06 Million | €372.42 Million | ▲ +10.4% |
| 2016 | 0.83x | €254.49 Million | €305.05 Million | — |